SAI
VRTX icon

Savvy Advisors Inc’s Vertex Pharmaceuticals VRTX Stock Holding History

Savvy Advisors Inc’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$934K Buy
1,881
+60
+3% +$26.6K 0.02% 547
2026
Q1 		$813K Buy
1,821
+61
+3% +$28.4K 0.02% 489
2025
Q4 		$798K Buy
1,760
+341
+24% +$147K 0.03% 419
2025
Q3 		$556K Buy
1,419
+512
+56% +$214K 0.03% 403
2025
Q2 		$404K Buy
907
+285
+46% +$131K 0.03% 409
2025
Q1 		$302K Buy
+622
New +$290K 0.03% 393

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Savvy Advisors Inc's VRTX Position: Q2 2026 in Review

Savvy Advisors Inc increased its Vertex Pharmaceuticals (VRTX) stake by 3.3% in Q2 2026, buying an estimated $26.6K and bringing the position to 1,881 shares worth $934K. The position accounts for 0.02% of the portfolio, ranked #547.

Savvy Advisors Inc first reported a position in VRTX in Q1 2025 and has held it in 6 quarters since. 1,762 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Savvy Advisors Inc held 1,881 shares of Vertex Pharmaceuticals worth $934K as of Q2 2026.
  • Savvy Advisors Inc bought 60 Vertex Pharmaceuticals shares in Q2 2026, an estimated $26.6K.
  • Vertex Pharmaceuticals made up 0.02% of Savvy Advisors Inc's portfolio in Q2 2026, its #547 holding.
  • Savvy Advisors Inc first reported a position in Vertex Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
  • 1,762 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Savvy Advisors Inc's 13F filing for Q2 2026, filed 3 Aug 2026.